Roles of the immune system in cancer: from tumor initiation to metastatic progression
The presence of inflammatory immune cells in human tumors raises a fundamental question in oncology: How do cancer cells avoid the destruction by immune attack? In principle, tumor development can be controlled by cytotoxic innate and adaptive immune cells; however, as the tumor develops from neopla...
Saved in:
Published in | Genes & development Vol. 32; no. 19-20; pp. 1267 - 1284 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
Cold Springs Harbor Laboratory Press
01.10.2018
Cold Spring Harbor Laboratory Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The presence of inflammatory immune cells in human tumors raises a fundamental question in oncology: How do cancer cells avoid the destruction by immune attack? In principle, tumor development can be controlled by cytotoxic innate and adaptive immune cells; however, as the tumor develops from neoplastic tissue to clinically detectable tumors, cancer cells evolve different mechanisms that mimic peripheral immune tolerance in order to avoid tumoricidal attack. Here, we provide an update of recent accomplishments, unifying concepts, and future challenges to study tumor-associated immune cells, with an emphasis on metastatic carcinomas. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 AC02-05CH11231 USDOE Office of Science (SC) Present address: Department of Clinical Genetics, Lund University, SE-221 85 Lund, Sweden. |
ISSN: | 0890-9369 1549-5477 1549-5477 |
DOI: | 10.1101/gad.314617.118 |